Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rubenstein

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
Journal of Surgical Oncology|April 1, 1997
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literatureP Guinan, D Stuhldreher, W Frank, et al.
Journal of Surgical Oncology|July 1, 1996
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude miceM Rubenstein, Y Mirochnik, P Chou, et al.
International Surgery|January 1, 1993
Bilateral orchiectomy in the management of stage D-2 prostate cancerP Guinan, R Firfer, P Targonski, et al.
Oncology|January 1, 1982
Mithramycin impairs the release of 45Ca from bone induced by prostaglandin E2 or multiple myeloma sera. Implications for a novel means of local tumor controlK M Anderson, M Rubenstein, H Sky-Peck
Methods and Findings in Experimental and Clinical Pharmacology|March 6, 2002
Biotinylation of antisense oligonucleotides does not alter lipofectin enhanced cellular uptake in prostate cancer cell linesM Rubenstein, Y Mirochnik, L Slobodskoy, et al.
Physical Review Letters|September 26, 2012
Controlling the folding and substrate-binding of proteins using polymer brushesBrenda M Rubenstein, Ivan Coluzza, Mark A Miller
Journal of the American Chemical Society|March 19, 1975
Letter: Levulinic esters. An alcohol protecting group applicable to some nucleosidesA Hassner, G Strand, M Rubenstein, et al.
Medical Oncology (Northwood, London, England)|March 1, 1997
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivationM Rubenstein, P Chou, Y Mirochnik, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapyM Johnson, M Shaw, M Rubenstein, et al.
Urological Research|January 1, 1987
Lymphocyte subsets in urologic cancer patientsM Shaw, P Ray, M Rubenstein, et al.
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
Journal of Surgical Oncology|April 1, 1997
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literatureP Guinan, D Stuhldreher, W Frank, et al.
Journal of Surgical Oncology|July 1, 1996
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude miceM Rubenstein, Y Mirochnik, P Chou, et al.
International Surgery|January 1, 1993
Bilateral orchiectomy in the management of stage D-2 prostate cancerP Guinan, R Firfer, P Targonski, et al.
Oncology|January 1, 1982
Mithramycin impairs the release of 45Ca from bone induced by prostaglandin E2 or multiple myeloma sera. Implications for a novel means of local tumor controlK M Anderson, M Rubenstein, H Sky-Peck
Methods and Findings in Experimental and Clinical Pharmacology|March 6, 2002
Biotinylation of antisense oligonucleotides does not alter lipofectin enhanced cellular uptake in prostate cancer cell linesM Rubenstein, Y Mirochnik, L Slobodskoy, et al.
Physical Review Letters|September 26, 2012
Controlling the folding and substrate-binding of proteins using polymer brushesBrenda M Rubenstein, Ivan Coluzza, Mark A Miller
Journal of the American Chemical Society|March 19, 1975
Letter: Levulinic esters. An alcohol protecting group applicable to some nucleosidesA Hassner, G Strand, M Rubenstein, et al.
Medical Oncology (Northwood, London, England)|March 1, 1997
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivationM Rubenstein, P Chou, Y Mirochnik, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapyM Johnson, M Shaw, M Rubenstein, et al.
Urological Research|January 1, 1987
Lymphocyte subsets in urologic cancer patientsM Shaw, P Ray, M Rubenstein, et al.
Pageof 27